Drug intelligence / Profile preview

trans-chalcone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

trans-chalcone is a natural small molecule flavonoid and the thermodynamically stable isomer of chalcone, found in various plants. It exhibits a broad spectrum of pharmacological activities, including anti-inflammatory, antioxidant, anticancer, and anthelmintic properties. Mechanistically, it acts as a multi-target modulator of several signaling pathways, primarily activating cytoprotective pathways such as Nrf2, SIRT1, and AMPK, while suppressing pro-inflammatory signaling through the inhibition of NF-κB and the NLRP3 inflammasome. Additionally, trans-chalcone has been identified as a pore blocker for large-conductance calcium-activated potassium (BKCa) channels and an antagonist for nociceptive TRP channels (TRPV1 and TRPA1). Research suggests potential therapeutic applications in metabolic diseases like obesity and NAFLD, neurodegenerative conditions such as Parkinson's disease, cardiovascular injuries, and various cancers.

Other names
1,3-diphenyl-2-propen-1-one(E)-chalconeTC
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on trans-chalcone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trans-chalcone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call